These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38404124)

  • 1. Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models.
    Arrospide A; Ibarrondo O; Blasco-Aguado R; Larrañaga I; Alarid-Escudero F; Mar J
    Med Decis Making; 2024 May; 44(4):359-364. PubMed ID: 38404124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study.
    Beca JM; Chan KKW; Naimark DMJ; Pechlivanoglou P
    BMC Med Res Methodol; 2021 Dec; 21(1):282. PubMed ID: 34922454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer.
    Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J
    Med Decis Making; 2021 Feb; 41(2):179-193. PubMed ID: 33349137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weibull parametric model for survival analysis in women with endometrial cancer using clinical and T2-weighted MRI radiomic features.
    Li X; Marcus D; Russell J; Aboagye EO; Ellis LB; Sheeka A; Park WE; Bharwani N; Ghaem-Maghami S; Rockall AG
    BMC Med Res Methodol; 2024 May; 24(1):107. PubMed ID: 38724889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study.
    Gallacher D; Kimani P; Stallard N
    Med Decis Making; 2021 Jan; 41(1):37-50. PubMed ID: 33283635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A parametric additive hazard model for time-to-event analysis.
    Voeltz D; Hoyer A; Forkel A; Schwandt A; Kuß O
    BMC Med Res Methodol; 2024 Feb; 24(1):48. PubMed ID: 38402386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible parametric survival model for fitting time to event data in clinical trials.
    Liao JJZ; Liu GF
    Pharm Stat; 2019 Oct; 18(5):555-567. PubMed ID: 31037824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of survival (mortality) data: fitting Gompertz, Weibull, and logistic functions.
    Wilson DL
    Mech Ageing Dev; 1994 May; 74(1-2):15-33. PubMed ID: 7934205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the recursion formula of the Gompertz survival function to evaluate life-table data.
    Bassukas ID
    Mech Ageing Dev; 1996 Aug; 89(3):155-63. PubMed ID: 8844636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.
    Crowther MJ; Look MP; Riley RD
    Stat Med; 2014 Sep; 33(22):3844-58. PubMed ID: 24789760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exponentiated Weibull regression for time-to-event data.
    Khan SA
    Lifetime Data Anal; 2018 Apr; 24(2):328-354. PubMed ID: 28349290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.
    Du X; Li M; Zhu P; Wang J; Hou L; Li J; Meng H; Zhou M; Zhu C
    PLoS One; 2018; 13(8):e0200807. PubMed ID: 30133454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian inference in a piecewise Weibull proportional hazards model with unknown change points.
    Casellas J
    J Anim Breed Genet; 2007 Aug; 124(4):176-84. PubMed ID: 17651319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Gompertz and Weibull functions as descriptors for human mortality distributions and their intersections.
    Juckett DA; Rosenberg B
    Mech Ageing Dev; 1993 Jun; 69(1-2):1-31. PubMed ID: 8377524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis.
    Djalalov S; Beca J; Ewara EM; Hoch JS
    Pharmacoeconomics; 2019 Dec; 37(12):1525-1536. PubMed ID: 31571137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the code in the open-source saemix package to fit joint models of longitudinal and time-to-event data.
    Lavalley-Morelle A; Mentré F; Comets E; Mullaert J
    Comput Methods Programs Biomed; 2024 Apr; 247():108095. PubMed ID: 38422892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying conventional and saturated generalized gamma distributions in parametric survival analysis of breast cancer.
    Yavari P; Abadi A; Amanpour F; Bajdik C
    Asian Pac J Cancer Prev; 2012; 13(5):1829-31. PubMed ID: 22901130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the distribution of ischaemic stroke-specific survival time using an EM-based mixture approach with random effects adjustment.
    Ng SK; McLachlan GJ; Yau KK; Lee AH
    Stat Med; 2004 Sep; 23(17):2729-44. PubMed ID: 15316955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian and Classical Inference for the Generalized Log-Logistic Distribution with Applications to Survival Data.
    Muse AH; Mwalili S; Ngesa O; Almalki SJ; Abd-Elmougod GA
    Comput Intell Neurosci; 2021; 2021():5820435. PubMed ID: 34671390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric survival analysis using R: Illustration with lung cancer data.
    Kumar M; Sonker PK; Saroj A; Jain A; Bhattacharjee A; Saroj RK
    Cancer Rep (Hoboken); 2020 Aug; 3(4):e1210. PubMed ID: 32794636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.